Ilesol Pharmaceuticals is an industrial scale producer of full-spectrum CBD and non-detectable THC products. The company was founded in 2017 by two experts in pharmaceutical process engineering and optimization, medicinal plants extraction methods, active compounds isolation, hemp processing, cultivation, breeding, and optimization. In the first year we were providing services for big industry players. We launched our first products in early 2018. From the start, we are committed to providing our clients with specifically formulated products. This business model made us 1st European cannabinoid à la carte company. Currently, we are in a process of setting up production of pharmaceutical ingredients, cosmetic ingredients, and end consumer products.
Our CBD is derived from Croatian-grown hemp. We provide high purity isolated cannabinoids, THC-free and full-spectrum CBD oils of any potency. All of our products are third party tested and free of pesticides, toxic solvent residues, and heavy metals. We can fulfill large contracts.
Ilesol’s products are the pinnacle of CBD quality and enable our customers to buy wholesale CBD products straight from the manufacturer.
- Full Traceability and Guarantee of raw material origin
- Production according to the highest industrial standards
- Our products undergo rigorous quality control measures to ensure safety, stability, and efficacy. Our quality management team has extensive experience in pharmaceutical quality assurance.
- Analytical support from 3rd party accredited laboratory with accredited analytical methods
- Knowledge of cutting-edge extraction and purification technologies
- Our products contain a full spectrum of naturally occurring cannabinoids and terpenes